Jiafeng Zou

571 total citations
22 papers, 453 citations indexed

About

Jiafeng Zou is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Jiafeng Zou has authored 22 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 7 papers in Molecular Biology and 5 papers in Materials Chemistry. Recurrent topics in Jiafeng Zou's work include Nanoplatforms for cancer theranostics (10 papers), RNA Interference and Gene Delivery (4 papers) and Gold and Silver Nanoparticles Synthesis and Applications (4 papers). Jiafeng Zou is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), RNA Interference and Gene Delivery (4 papers) and Gold and Silver Nanoparticles Synthesis and Applications (4 papers). Jiafeng Zou collaborates with scholars based in China and Switzerland. Jiafeng Zou's co-authors include Hongyue Zheng, Fanzhu Li, Zhihong Zhu, Rui Ma, Ji‐Gang Piao, Feng Gao, Xiaojie Chen, Ke Zhang, Jingjing Zhu and Minbo Lan and has published in prestigious journals such as Chemical Engineering Journal, Biochemical and Biophysical Research Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Jiafeng Zou

22 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiafeng Zou China 12 169 150 126 94 68 22 453
Zhiyong Qian China 16 199 1.2× 115 0.8× 137 1.1× 46 0.5× 91 1.3× 36 519
Lingran Du China 11 141 0.8× 109 0.7× 188 1.5× 73 0.8× 59 0.9× 22 457
Haiqin Huang China 14 206 1.2× 215 1.4× 191 1.5× 103 1.1× 40 0.6× 34 623
Xiyou Du China 14 274 1.6× 197 1.3× 190 1.5× 74 0.8× 92 1.4× 27 596
Sankalp Gharat India 10 129 0.8× 187 1.2× 199 1.6× 126 1.3× 66 1.0× 25 615
Seok Min Kwon South Korea 8 163 1.0× 279 1.9× 282 2.2× 94 1.0× 84 1.2× 15 645
Martina Di Francesco Italy 15 110 0.7× 130 0.9× 140 1.1× 101 1.1× 27 0.4× 25 483
Moonjeong Choi South Korea 11 99 0.6× 146 1.0× 181 1.4× 85 0.9× 47 0.7× 17 612
Vanshikha Singh India 11 122 0.7× 162 1.1× 165 1.3× 136 1.4× 52 0.8× 13 506

Countries citing papers authored by Jiafeng Zou

Since Specialization
Citations

This map shows the geographic impact of Jiafeng Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiafeng Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiafeng Zou more than expected).

Fields of papers citing papers by Jiafeng Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiafeng Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiafeng Zou. The network helps show where Jiafeng Zou may publish in the future.

Co-authorship network of co-authors of Jiafeng Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Jiafeng Zou. A scholar is included among the top collaborators of Jiafeng Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiafeng Zou. Jiafeng Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Jiafeng, Xinlin Zhao, Yanwen Wang, et al.. (2025). An anti-miR-301a and zinc coordination driven nanozyme loaded in nanoparticle for oral therapy of inflammatory bowel disease based on colitis microenvironment regulation. Chemical Engineering Journal. 511. 161997–161997. 2 indexed citations
3.
Chen, You, Yang Chen, Xiang Li, et al.. (2024). ROS-responsive nano-medicine for navigating autophagy to enhance targeted therapy of inflammatory bowel disease. International Journal of Pharmaceutics. 659. 124117–124117. 13 indexed citations
4.
Yi, Cheng, Jiafeng Zou, Muye He, et al.. (2024). Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy. Journal of Controlled Release. 367. 167–183. 13 indexed citations
6.
Chen, Yang, et al.. (2024). An Oral H2S Responsive Cu5.4O Nanozyme Platform with Strong ROS/H2S Scavenging Capacity for the Treatment of Colitis. ACS Applied Materials & Interfaces. 17(1). 617–631. 6 indexed citations
7.
Zou, Jiafeng, et al.. (2024). Tofacitinib Citrate Coordination‐Based Dual‐Responsive/Scavenge Nanoplatform Toward Regulate Colonic Inflammatory Microenvironment for Relieving Colitis. Advanced Healthcare Materials. 13(30). e2401869–e2401869. 11 indexed citations
8.
Zou, Jiafeng, Muye He, You Chen, et al.. (2023). Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition. ACS Applied Materials & Interfaces. 15(46). 53198–53216. 3 indexed citations
9.
Yuan, Zeting, Hai He, Jiafeng Zou, et al.. (2023). Polydopamine-coated ferric oxide nanoparticles for R848 delivery for photothermal immunotherapy in breast cancer. International Journal of Pharmaceutics. 644. 123249–123249. 9 indexed citations
10.
Zou, Jiafeng, et al.. (2023). Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice. International Journal of Pharmaceutics. 635. 122741–122741. 37 indexed citations
11.
Zou, Jiafeng, Zeting Yuan, Xiaojie Chen, et al.. (2023). Hydrogen sulfide responsive nanoplatforms: Novel gas responsive drug delivery carriers for biomedical applications. Asian Journal of Pharmaceutical Sciences. 19(1). 100858–100858. 14 indexed citations
12.
Wang, Junshan, et al.. (2023). pH-Sensitive Nanoparticles for Colonic Delivery Anti-miR-301a in Mouse Models of Inflammatory Bowel Diseases. Nanomaterials. 13(20). 2797–2797. 13 indexed citations
13.
Yang, Ying, et al.. (2022). Single, Self-Born RP-Au-PR Motif Boosts 19-Fold Photoluminescence Quantum Yield of Metal Nanocluster. Acta Chimica Sinica. 80(1). 1–1. 2 indexed citations
14.
Luo, Jingwen, et al.. (2021). Deoxycholic acid-functionalised nanoparticles for oral delivery of rhein. European Journal of Pharmaceutical Sciences. 159. 105713–105713. 35 indexed citations
15.
Shi, Xiaowei, Rui Ma, Ying Cheng, et al.. (2020). iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas. Biochemical and Biophysical Research Communications. 527(1). 117–123. 40 indexed citations
16.
Chen, Xiaojie, Jiafeng Zou, Ke Zhang, et al.. (2020). Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment. Acta Pharmaceutica Sinica B. 11(1). 271–282. 65 indexed citations
17.
Yao, Wendong, Jiafeng Zou, Hongyue Zheng, et al.. (2019). Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis. International Journal of Pharmaceutics. 563. 91–100. 54 indexed citations
18.
Chen, Junjie, Ying Cheng, Rui Ma, et al.. (2019). Novel Strategy of Gene Delivery System Based on Dendrimer Loaded Recombinant Hirudine Plasmid for Thrombus Targeting Therapy. Molecular Pharmaceutics. 16(4). 1648–1657. 16 indexed citations
19.
Zhu, Jiazhen, Jiafeng Zou, Chaofeng Mu, et al.. (2019). Intranasal administration of pullulan-based nanoparticles for enhanced delivery of adriamycin into the brain: in vitro and in vivo evaluation.. PubMed. 74(1). 39–46. 7 indexed citations
20.
Han, Shunping, Hongyue Zheng, Rui Ma, et al.. (2018). A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system. International Journal of Nanomedicine. Volume 13. 5937–5952. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026